Tilray Brands announced a series of business initiatives marking its next phase of global growth, expanding its leadership across healthcare, cannabis and beverage while strengthening its ability to expand internationally and capture emerging market opportunities. Tilray Medical is establishing its first fully vertically integrated, patient-centric medical platform which combines pharmaceutical-grade medical cannabis cultivation and production with clinical care, dispensing services, and pharmaceutical distribution.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Red White & Bloom Brands’ subsidiary, Emblem Cannabis, selected as successful bidder to acquire Health Canada-licensed manufacturing operations
2 | Aurora Cannabis accelerates accretive acquisition of Safari Flower Company, expanding EU GMP capacity
3 | Cannara reports Q2 fiscal 2026 results with continued profitability, strong operating cash flow and #1 retail market share in Québec
Top Cannabis Stocks Apr. 10 to Apr. 16, 2026
1. T.CURA | 4,332 views | Curaleaf Holdings Inc.
2. T.TLRY | 2,687 views | Tilray Brands Inc.
3. T.LABS | 2,928 views | Medipharm Labs Corp.
4. C.TGIF| 533 views | 1933 Industries Inc.
5. T.OGI | 504 views | Organigram Global Inc.
6. C.BLO | 455 views | Cannabix Technologies Inc.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
